Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

Additionally, the estimated total striatal volume in the AG group (114.5 ± 12.76 mm 3 ) showed a trend toward an increase compared to the IG group (97.68 ± 29.90 mm 3 ) and the FG group (64.36 ± 1.90 mm 3 ) ( Figures 6C , D ) with a calculated mean error coefficient of 3.2% (see Supplementary Table 1 ).
In this subgroup, patients with a benefit rate of ≤10% had longer DFS without adjuvant chemotherapy (HR=2.05, 95% CI 1.50 to 2.80, p<0.001, figure 4F ), while those with a benefit rate of >10% and ≤25% showed a trend of prolonged DFS with adjuvant chemotherapy, although not significant (HR=1.06, 95% CI 0.49 to 2.80, p=0.883, figure 4G ), suggesting that the adjuvant chemotherapy benefit rate may support individualized treatment decisions for candidates for adjuvant chemotherapy.
A Phase IIa pilot study in 16 kidney transplant patients confirmed the feasibility of the ex vivo administration of Mirococept at 10 mg/kidney prior to transplantation and showed a trend towards more rapid recovery of graft function compared with control organs. 21 The first EMPIRIKAL Phase II study set out to evaluate the dose and efficacy of Mirococept in reducing DGF rates in deceased donor kidney transplantation. 22 The design was to test a dose range of 5–25 mg in cohorts of 80 patients for each dose with a maximum number of seven cohorts.
In another series of 289 patients with CRC, high mRNA expression levels of α‐SMA showed a trend toward shorter overall survival and a combination of CAF and M2 macrophage mRNA markers: α‐SMA, fibroblast‐specific protein 1, and fibroblast activation protein together predicted the outcome. 29 These suggest that for improved survival prediction, perhaps combinatorial analysis with other markers may prove helpful.